Case reports have described marked improvement in hand involvement [73], and a dedicated phase 3 trial (ADHand) is set to read out in late 2025 [101]
Estos datos apoyan un posible cambio hacia el uso de terapia oral con agonistas de receptor GLP-1, como orforglipron, de forma ms temprana como un pilar fundamental para el manejo de la diabetes tipo 2
All cases resolved after stopping the medication
Glutathione is believed to inhibit the activity of tyrosinase, thereby reducing melanin synthesis and resulting in lighter and brighter skin
Data was analyzed using Fischers exact test, paired T-test, and Wilcoxon signed rank test
Between 50% and 70% of women with PCOS have clinically significant insulin resistance, regardless of their body weight